CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.360
+0.040 (1.20%)
Aug 5, 2026, 10:22 AM EDT - Market open
CytomX Therapeutics Employees
CytomX Therapeutics had 69 employees as of December 31, 2025. The number of employees decreased by 52 or -42.98% compared to the previous year.
Employees
69
Change (1Y)
-52
Growth (1Y)
-42.98%
Revenue / Employee
$515,101
Profits / Employee
-$900,623
Market Cap
731.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | -52 | -42.98% | 69 | 0 |
| Dec 31, 2024 | 121 | -1 | -0.82% | 119 | 2 |
| Dec 31, 2023 | 122 | 4 | 3.39% | 120 | 2 |
| Dec 31, 2022 | 118 | -60 | -33.71% | 116 | 2 |
| Dec 31, 2021 | 178 | 32 | 21.92% | 174 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Pharming Group | 407 |
| Rigel Pharmaceuticals | 174 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| AgomAb Therapeutics NV | 62 |
| Oculis Holding AG | 60 |
| Crescent Biopharma | 55 |
CTMX News
- 2 days ago - CytomX Therapeutics appoints Alejandra Carvajal as chief legal officer - TheFly
- 2 days ago - CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer - GlobeNewsWire
- 6 days ago - CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 - GlobeNewsWire
- 9 days ago - CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors - GlobeNewsWire
- 2 months ago - CytomX Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - CytomX Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - CytomX Therapeutics expands licensing agreement with Regeneron - TheFly
- 2 months ago - CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer - GlobeNewsWire